No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Inhibikase Therapeutics Completes Merger With CorHepta Pharmaceuticals
Inhibikase Announces Expansion of Senior Leadership Team
Press Release: Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company's Growth
Express News | Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Inhibikase Therapeutics Analyst Ratings